Confirmed by a Gastric Emptying Study A gastric emptying study must confirm your gastroparesis diagnosis
In one observational study involving adults with type 2 diabetes and ischemic heart disease, tirzepatide was linked to a 40% lower risk of a composite outcome, including heart attack, stroke, and all-cause mortality (HR 0.60)
Listen to it rather than cleaning your plate
Side effects associated with the use of this medication such as slight nausea, constipation, and headaches were reported by some users but could usually be managed if instructions given by healthcare professionals were followed properly at all times
It just requires a disciplined, methodical approach
Questions to raise with a clinician or study team Medication overlap: Ask how insulin or sulfonylureas are handled